Despite being satisfied with treatment, the overwhelming majority of patients with idiopathic pulmonary fibrosis (IPF) experience side effects, which commonly impact quality of life (QOL), say findings from patients with the disease.1 The findings come from 106 patients across the United States participating in a qualitative interview or an online survey, the majority of whom … Read more
Primary care physicians (PCPs) often face challenges in diagnosing complex pulmonary issues in patients, particularly when nonspecific symptoms appear similar to cardiovascular issues, asthma, or chronic obstructive pulmonary disease. However, clinicians can cover both pulmonary and cardiovascular concerns during an exam, potentially shortening delays in the diagnosis of interstitial lung diseases (ILDs), including pulmonary fibrosis … Read more
SAN FRANCISCO — Dogs trained to sniff out lung disease may need to look for another line of work if an “electronic nose” sensor in development makes it into widespread clinical practice. In a multicenter cohort study of 589 patients with a diagnosis of interstitial lung disease (ILD) by multidisciplinary team discussion and evidence of … Read more
Announcing a new article publication for BIO Integration journal. Pulmonary fibrosis (PF) is a progressive interstitial lung disease characterized by excessive extracellular matrix deposition and tissue scarring, and leading to impaired lung function and respiratory failure. Although current treatments, such as pirfenidone and nintedanib, slow disease progression, they fail to completely halt or reverse fibrosis … Read more